A clinical trial of immunosuppressive therapy for myocarditis

New England Journal of Medicine

Volumn 333, Issue 5, 1995, Pages 269-275

  Mason, Jay W ^a   O'connell, John B ^a   Herskowitz, Ahvie ^a   Rose, Noel R ^a   Mcmanus, Bruce M ^a   Billingham, Margaret E ^a   Moon, Thomas E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; AZATHIOPRINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; MALE; MULTIVARIATE ANALYSIS; MYOCARDITIS; MYOCARDIUM; PREDNISONE; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029024004     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199508033330501     Document Type: Article

References (26)

1. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23: 586-590
2. O'Connell JB, Mason JW Diagnosing and treating active myocarditis. West J Med 1989; 150: 431-435
3. Matsumori A, Kawai C An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 1982; 66: 355-360
4. Woodruff JF Viral myocarditis: a review. Am J Pathol 1980; 101: 425-484
5. Neumann DA, Rose NR, Ansari AA, Herskowitz A Induction of multiple heart autoantibodies in mice with coxsackievirus B3 and cardiac myosin- induced autoimmune myocarditis. J Immunol 1994; 152: 343-350
6. Yamada T, Matsumori A, Sasayama S Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994; 89: 846-851
7. Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S Cytokine and murine coxsackievirus B3 myocarditis: interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 1994; 89: 2836-2842
8. Mason JW, Billingham ME, Ricci DR Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 1980; 45: 1037-1044
9. Dec GW Jr, Palacios IF, Fallon JT, Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-890
10. Mortensen SA, Baandrup U, Buch J, Bendtzen K, Hvid-Jacobsen K Immunosuppressive therapy of biopsy proven myocarditis: experiences with corticosteroids and cyclosporin. Int J Immunother 1985; 1: 35-45
11. Jones SSR, Herskowitz A, Hutchins GM, Baughman KL Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 1991; 68: 370-376
12. Mason JW, O'Connell JB Clinical merit of endomyocardial biopsy. Circulation 1989; 79: 971-979
13. O'Connell JB, Mason JW The applicability of results of streamlined trials to clinical practice: the Myocarditis Treatment Trial. Stat Med 1990; 9: 193-197
14. Hahn EA, Hartz VL, Moon TE, et al. The Myocarditis Treatment Trial: design, methods and patient enrollment. Eur Heart J (in press).
15. Mason JW Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol 1978; 41: 887-892
16. Aretz HT, Billingham ME, Edwards WD, Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14
17. Aretz HT, Billingham ME, Edwards WD The utility of the Dallas criteria for the histopathological diagnosis of myocarditis in endomyocardial biopsy specimens. Circulation 1993; 88: Suppl: I-552 abstract.
18. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839-846
19. Burek CL, Rose NR. Autoantibodies. In: Colvin RB, Bhan AK, McCluskey RT, eds. Diagnostic immunopathology. New York: Raven Press, 1995:207-30.
20. SAS/STAT user's guide: release 6. 4th ed. Carey, N.C.: SAS Institute, 1990.
21. Myocarditis Treatment Trial (MTT) Investigators. Incidence and clinical characteristics of myocarditis. Circulation 1991; 84: Suppl II: II-2 abstract.
22. McManus BM, Chow LH, Wilson JE, Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993; 68: 159-169
23. Lodge PA, Herzum M, Olszewski J, Huber SA Coxsackievirus B-3 myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 1987; 128: 455-463
24. Rose NR, Neumann DA, Herskowitz A Coxsackievirus myocarditis. Adv Intern Med 1992; 37: 411-429
25. Ensley RD, Ives M, Zhao L, McMillan M, Shelby J, Barry WH Effects of alloimmune injury on contraction and relaxation in cultured myocytes and intact cardiac allografts. J Am Coll Cardiol 1994; 24: 1769-1778
26. Cohn JN, Levine TB, Olivari MT, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823